Event: The 2^nd Annual World Pharmaceutical (China) Summit 2010
Date(s): May 19 - 21, 2010
Venue: InterContinental Pudong Hotel, Shanghai China
Weblink: www.innchinc.com  
Contact: Jonas Jiang
Tel: +86-21-51920620
Email: wpcs@innchinc.com

 

China's pharmaceutical market looks set to grow even further in the short-term, with the establishment of an Essential Medicines System during the 2009 - 2011 periods. The plan calls for an estimated 300-400 essential medicines to be made available at all public facilities, starting at the grassroots level. Under the economic recession, many big pharmas are looking for new ways out. For those companies looking for drug approval from China's SFDA, teaming up with a Chinese CRO could be critical. A local CRO that has a good working relationship with SFDA can speed up approval, monitor the process and resolve problematic areas without delay or even before they arise. Whatever the category, China俿 CROs offer significant opportunities for global clinical R&D through world-class research and laboratory facilities, an abundant supply of internationally trained scientists and medical professionals, and access to large treatment-na飗e patient populations.

 

Last year in September we embraced the opening of the World Pharmaceutical (China) Summit (WPCS2009), expectedly a grand gathering for executives of the pharmaceutical industry in China and elsewhere around the world. This annual summit themed China's pharmaceutical industry has been well received and acclaimed by participants. To satisfy their demand for further communication and co-operations, we organize 2nd Annual World Pharmaceutical (China) Summit (WPCS2010), looking forward to sharing with them the latest development and achievements of the industry and building the partnering platform between big pharmas and CROs. Apart from the keynote topics presented in the summit, this year's WPCS will also cover the up-to-date topics. We sincerely wish that all the participants will benefit immensely from the four-day trip.

 

- Representing national determination to apply the healthcare reform

- Gathering all the key stakeholders, from the big pharmas, local governments to leading CROs and academia

- Up-to-date information of the uncertain basic medicine catalogue

- In-depth analysis on the new drug R&D and sustainable innovation

- Eyes on the most leading preclinical and clinical research providers

- Evaluating Longer-term partnerships to big pharmas and CROs

- Offering the full spectrum of information from clinical development services, discovery platforms and drug delivery technologies

What to Expect in WPCS2010

- ONLY event to hold face to face meetings with senior officials from government, biopharmas and CROs

- 30+ high-level & experienced speakers

- Top 20 pharmaceutical companies

- Top 20 CRO companies

- 300+ senior level participants

- VALUE-ADDED workshops on regulatory framework and legal practice development

- EXTRAODINARY sightseeing to the Shanghai EXPO

 

 

MAY 19, WEDNESDAY

Workshop A: Intellectual Property Protection: Is It Getting Better?

Workshop B: Discovering the Up-to-date Regulatory Framework and Legal Practice in the New Drug R&D Outsourcing

 

MAY 20, THURSDAY

Session 1: Eyes on China: Influences Of the New Healthcare Reform

Session 2: Strategy Outlook: Local and Global Pharmaceutical Movement

 

MAY 21, FRIDAY

Session 3: Dialogue among Big Pharmas CROs and Biotech Companies

Session 4: Streamline of Developing New Medicine with Cutting-Edge Technologies

 

MAY 22, SATURDAY

Post-conference Sightseeing Tour (2010 Shanghai EXPO)